SOX2 gene amplification is frequently up-regulated in NSCLC [18], [19] and is associated with poor prognosis [17], but recently results show that high SOX2 levels predict better outcome in NSCLC [16]. This evidence concerns the gene SOX2 and non-small cell lung carcinoma.